Healthcare Global Enterprises Ltd vs Sharma East India Hosp And Medical Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Healthcare Global Enterprises Ltd is ₹ 584.8 as of 30 Oct 15:30 . The P/E Ratio of Healthcare Global Enterprises Ltd changed from 69.7 on March 2022 to 570.3 on March 2026 . This represents a CAGR of 52.26% over 5 yearsThe P/E Ratio of Sharma East India Hosp and Medical Research Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Healthcare Global Enterprises Ltd changed from ₹ 2394 crore on March 2021 to ₹ 7833 crore on March 2026 . This represents a CAGR of 21.84% over 6 yearsThe Market Cap of Sharma East India Hosp and Medical Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Healthcare Global Enterprises Ltd for the Jun '26 is ₹ 708.16 crore as compare to the Mar '26 revenue of ₹ 665.92 crore. This represent the growth of 6.34% The revenue of Sharma East India Hosp and Medical Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Healthcare Global Enterprises Ltd for the Jun '26 is ₹ 135.32 crore as compare to the Mar '26 ebitda of ₹ 106.76 crore. This represent the growth of 26.75% The ebitda of Sharma East India Hosp and Medical Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Healthcare Global Enterprises Ltd changed from ₹ 13.63 crore to ₹ 16.46 crore over 9 quarters. This represents a CAGR of 8.75% The net profit of Sharma East India Hosp and Medical Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Healthcare Global Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sharma East India Hosp and Medical Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Limited was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a Private Limited Company.
The name of the Company was changed to HealthCare Global Enterprises Private Limited on November 14, 2005.
Thereafter, it was converted into a Public Limited Company and the name of the Company was changed to Healthcare Global Enterprises Limited on July 5, 2006. Presently, the Company is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.
Under the 'HCG' brand, the Company operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed by the AERB.

About Sharma East India Hosp and Medical Research Ltd

Sharma East India Hospitals & Medical Research Limited was incorporated on November 16, 1989.
The Company is engaged in providing medical and healthcare services and real estate services and is presently running a multi-specialty hospital in the name of 'Jaipur Hospital' at Lal Kothi, at Rajasthan since 1989. As far as the achievements of the Company are concerned, the first assessment of the Company was conducted by National Accreditation Board for Hospitals and Health Care Providers (NABH), NABH accreditation system is one of the methods for commitment to quality enhancement throughout whole of the health care system in India.
It involves all professional and service groups to ensure that high quality in health care is achieved, while minimizing the inherent risks associated with modern health care delivery.

FAQs for the comparison of Healthcare Global Enterprises Ltd and Sharma East India Hosp and Medical Research Ltd

Which company has a larger market capitalization, Healthcare Global Enterprises Ltd or Sharma East India Hosp and Medical Research Ltd?

Market cap of Healthcare Global Enterprises Ltd is 8,731 Cr while Market cap of Sharma East India Hosp and Medical Research Ltd is 26 Cr

What are the key factors driving the stock performance of Healthcare Global Enterprises Ltd and Sharma East India Hosp and Medical Research Ltd?

The stock performance of Healthcare Global Enterprises Ltd and Sharma East India Hosp and Medical Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Healthcare Global Enterprises Ltd and Sharma East India Hosp and Medical Research Ltd?

As of November 1, 2026, the Healthcare Global Enterprises Ltd stock price is INR ₹584.8. On the other hand, Sharma East India Hosp and Medical Research Ltd stock price is INR ₹80.0.

How do dividend payouts of Healthcare Global Enterprises Ltd and Sharma East India Hosp and Medical Research Ltd compare?

To compare the dividend payouts of Healthcare Global Enterprises Ltd and Sharma East India Hosp and Medical Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.